These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 3447890)
41. Fitting the two-stage clonal expansion model based on exact hazard to the ED01 data using SAS NLIN. Lensing SY; Kodell RL Risk Anal; 1995 Apr; 15(2):233-45. PubMed ID: 7597259 [TBL] [Abstract][Full Text] [Related]
42. A model for dose rate and duration of exposure effects in radiation carcinogenesis. Thomas DC Environ Health Perspect; 1990 Jul; 87():163-71. PubMed ID: 2269222 [TBL] [Abstract][Full Text] [Related]
43. Relationship between the shape of dose-response curves and background tumor rates. Gaylor DW Regul Toxicol Pharmacol; 1992 Aug; 16(1):2-9. PubMed ID: 1410654 [TBL] [Abstract][Full Text] [Related]
44. Using cell replication data in mathematical modeling in carcinogenesis. Portier CJ; Kopp-Schneider A; Sherman CD Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):79-86. PubMed ID: 8013428 [TBL] [Abstract][Full Text] [Related]
45. A review of the chronic toxicity, carcinogenicity, and possible mechanisms of action of inorganic acid mists in animals. Swenberg JA; Beauchamp RO Crit Rev Toxicol; 1997 May; 27(3):253-9. PubMed ID: 9189654 [TBL] [Abstract][Full Text] [Related]
46. Evidence of a "clear and consistent threshold" for bladder and liver cancer in the large ED01 carcinogenicity study. Crump KS; Clewell HJ Toxicol Sci; 2003 Aug; 74(2):485; author reply 485-6. PubMed ID: 12730607 [No Abstract] [Full Text] [Related]
47. Hormesis and dose-response-mediated mechanisms in carcinogenesis: evidence for a threshold in carcinogenicity of non-genotoxic carcinogens. Fukushima S; Kinoshita A; Puatanachokchai R; Kushida M; Wanibuchi H; Morimura K Carcinogenesis; 2005 Nov; 26(11):1835-45. PubMed ID: 15975961 [TBL] [Abstract][Full Text] [Related]
48. Analysis of modifying factors in chemical carcinogenesis. Cohen SM Prog Exp Tumor Res; 1991; 33():21-40. PubMed ID: 2028024 [No Abstract] [Full Text] [Related]
49. The study of tumor promotion in a cell culture model for mouse skin--a tissue that exhibits multistage carcinogenesis in vivo. Yuspa SH; Hennings H; Kulesz-Martin M; Lichti U Carcinog Compr Surv; 1982; 7():217-30. PubMed ID: 6121622 [No Abstract] [Full Text] [Related]
50. Modifying effects of antioxidants on chemical carcinogenesis. Ito N; Hirose M; Fukushima S; Tsuda H; Tatematsu M; Asamoto M Toxicol Pathol; 1986; 14(3):315-23. PubMed ID: 3787113 [TBL] [Abstract][Full Text] [Related]
51. Dose-dependent promoting effect of dextran sodium sulfate on mouse colon carcinogenesis initiated with azoxymethane. Suzuki R; Kohno H; Sugie S; Tanaka T Histol Histopathol; 2005 Apr; 20(2):483-92. PubMed ID: 15736053 [TBL] [Abstract][Full Text] [Related]
52. [Methods of risk assessment from data of experimental carcinogenesis studies]. Roller M; Csicsaky M; Pott F Zentralbl Hyg Umweltmed; 1992 Mar; 192(6):479-93. PubMed ID: 1315551 [TBL] [Abstract][Full Text] [Related]
53. Exposure of Sprague-Dawley rats to a 50-Hertz, 100-microTesla magnetic field for 27 weeks facilitates mammary tumorigenesis in the 7,12-dimethylbenz[a]-anthracene model of breast cancer. Thun-Battersby S; Mevissen M; Löscher W Cancer Res; 1999 Aug; 59(15):3627-33. PubMed ID: 10446973 [TBL] [Abstract][Full Text] [Related]
54. Milestones in chemical carcinogenesis. Miller EC; Miller JA Semin Oncol; 1979 Dec; 6(4):445-60. PubMed ID: 394329 [No Abstract] [Full Text] [Related]
55. Additive and multiplicative relative risk in the two-stage clonal expansion model of carcinogenesis. Kodell RL; Krewski D; Zielinski JM Risk Anal; 1991 Sep; 11(3):483-90. PubMed ID: 1947353 [TBL] [Abstract][Full Text] [Related]
56. A stochastic model of carcinogenesis incorporating certain observations from chemical and radiation dose-response data. Brodsky A Health Phys; 1978 Aug; 35(2):421-8. PubMed ID: 701047 [No Abstract] [Full Text] [Related]
57. Two-stage models of tumor incidence for historical control animals in the National Toxicology Program's carcinogenicity experiments. Portier CJ; Bailer AJ J Toxicol Environ Health; 1989; 27(1):21-45. PubMed ID: 2724366 [TBL] [Abstract][Full Text] [Related]
58. [The testing of the carcinogenicity of dispirotripiperazine derivatives by combined administration with sodium nitrite]. Lavrik OI; Kinzirskiĭ AS; Shashkina LF; Ivanova VM; Kruglova ON Eksp Klin Farmakol; 1993; 56(3):54-7. PubMed ID: 8219995 [TBL] [Abstract][Full Text] [Related]
59. Let us forget "tumour promotion" and start thinking about mechanisms of non-genotoxic carcinogenicity. Roe FJ APMIS Suppl; 1988; 2():91-9. PubMed ID: 3179036 [TBL] [Abstract][Full Text] [Related]
60. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2001 Jul; (499):7-340. PubMed ID: 12087422 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]